Nifty

:

25244.75

Sensex

:

82755.51

200.40 (0.80%)
700.40 (0.85%)

Login

Nifty
Sensex

:
:

25244.75
82755.51

200.40 (0.80%)
700.40 (0.85%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

58/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

434.85

25-Jun-2025

Open
High
Low
Previous Close

424.95
443.4
424.95
428.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5565
2410006.6
476.9
270.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

574.58
12.68
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

496.17
N/A
1.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.63
12.13
0.07

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.95
7.87
-0.82

PAT CAGR (%)

10 Years
5 Years
3 Years

18.63
-
-11.22

P:E (Median)

8 Years
5 Years
3 Years

10.50
13.12
14.76

P:BV (Average)

8 Years
5 Years
3 Years

0.59
0.85
0.79

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.79
6.38
5.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 194.04 175.16 10.78% 172.54 131.23 31.48% 167.02 170.19 -1.86% 105.86 98.63 7.33%
Expenses 171.49 153.88 11.44% 149.63 118.23 26.56% 156.75 157.06 -0.20% 91.58 85.16 7.54%
EBITDA 22.55 21.28 5.97% 22.91 13.00 76.23% 10.27 13.13 -21.78% 14.28 13.47 6.01%
EBIDTM 11.62% 12.15% 13.28% 9.91% 6.15% 7.71% 13.49% 13.66%
Other Income 6.77 3.91 73.15% 1.74 2.42 -28.10% 10.71 2.93 265.53% 1.56 2.06 -24.27%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 4.49 5.72 -21.50% 5.20 6.30 -17.46% 6.17 6.21 -0.64% 5.76 7.32 -21.31%
PBT 24.83 19.47 27.53% 29.36 9.12 221.93% 14.81 9.85 50.36% 10.08 8.21 22.78%
Tax 10.04 6.96 44.25% 5.28 0.93 467.74% 5.55 4.40 26.14% 5.63 3.87 45.48%
PAT 14.79 12.51 18.23% 24.08 8.19 194.02% 9.26 5.45 69.91% 4.45 4.34 2.53%
PATM 7.62% 7.14% 13.96% 6.24% 5.54% 3.20% 4.20% 4.40%
EPS 11.04 9.34 18.20% 17.97 6.11 194.11% 6.91 4.07 69.78% 3.32 3.24 2.47%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 194.97 195.16 -0.10% 176.86 143.42 23.32% 167.45 167.72 -0.16% 108.61 95.15 14.15%
Expenses 165.97 175.68 -5.53% 158.50 131.38 20.64% 162.54 149.97 8.38% 97.35 84.75 14.87%
EBITDA 29.00 19.48 48.87% 18.36 12.04 52.49% 4.91 17.75 -72.34% 11.26 10.40 8.27%
EBIDTM 14.87% 9.98% 10.38% 8.39% 2.93% 10.58% 10.37% 10.93%
Other Income 6.76 3.92 72.45% 2.03 2.35 -13.62% 10.58 3.05 246.89% 1.59 2.26 -29.65%
Interest 0.01 0.02 -50.00% 0.01 0.07 -85.71% 0.02 0.02 0.00% 0.02 0.06 -66.67%
Depreciation 4.71 5.91 -20.30% 5.41 6.54 -17.28% 6.40 6.44 -0.62% 5.98 7.55 -20.79%
PBT 31.04 17.47 77.68% 24.88 7.78 219.79% 9.07 14.34 -36.75% 6.85 5.05 35.64%
Tax 10.04 6.96 44.25% 5.28 0.93 467.74% 5.56 4.40 26.36% 5.63 3.87 45.48%
PAT 21.00 10.51 99.81% 19.60 6.85 186.13% 3.51 9.94 -64.69% 1.22 1.18 3.39%
PATM 10.77% 5.39% 11.08% 4.78% 2.10% 5.93% 1.12% 1.24%
EPS 15.71 7.86 99.87% 14.66 5.12 186.33% 2.63 7.43 -64.60% 0.91 0.88 3.41%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 639.46 575.21 537.66 576.71 514.62 320.23 301.84 355.07 375.45 402.69 451.88 Net Sales Growth 11.17% 6.98% -6.77% 12.07% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% Cost Of Goods Sold 374.79 352.22 336.70 377.50 336.68 176.81 181.78 205.42 186.69 194.64 213.05 Gross Profit 264.67 223.00 200.96 199.22 177.94 143.42 120.06 149.65 188.76 208.05 238.82 GP Margin 41.39% 38.77% 37.38% 34.54% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% Total Expenditure 569.45 514.32 476.14 507.89 467.76 277.16 267.55 311.51 328.16 323.14 364.94 Power & Fuel Cost - 4.99 4.17 3.78 3.39 3.41 3.50 3.02 3.08 2.90 3.28 % Of Sales - 0.87% 0.78% 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% Employee Cost - 57.57 47.67 43.75 35.89 33.79 30.26 27.82 25.02 25.02 27.26 % Of Sales - 10.01% 8.87% 7.59% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% Manufacturing Exp. - 22.40 25.46 25.48 20.63 18.35 18.98 34.28 75.01 58.94 73.60 % Of Sales - 3.89% 4.74% 4.42% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% General & Admin Exp. - 21.23 18.63 15.01 13.76 15.22 9.79 11.86 12.20 10.85 14.36 % Of Sales - 3.69% 3.47% 2.60% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% Selling & Distn. Exp. - 55.62 43.24 42.37 57.40 29.59 23.24 29.11 26.17 30.78 33.39 % Of Sales - 9.67% 8.04% 7.35% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% Miscellaneous Exp. - 0.31 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 33.39 % Of Sales - 0.05% 0.05% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 70.01 60.89 61.52 68.82 46.86 43.07 34.29 43.56 47.29 79.55 86.94 EBITDA Margin 10.95% 10.59% 11.44% 11.93% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% Other Income 20.78 11.32 10.17 8.43 17.76 3.58 4.51 1.19 3.10 0.67 0.55 Interest 0.00 0.00 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 40.70 Depreciation 21.62 25.55 31.37 32.58 34.28 31.05 32.95 32.73 39.32 40.47 44.74 PBT 79.08 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 Tax 26.50 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 Tax Rate 33.51% 34.62% 28.17% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% PAT 52.58 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 PAT before Minority Interest 52.58 30.50 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.22% 5.30% 5.39% 8.49% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% PAT Growth 72.45% 5.32% -40.89% -9.73% - - - - - -73.63% EPS 39.24 22.76 21.61 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 647.89 601.45 555.51 600.18 548.12 339.33 321.89 372.41 400.04 418.27 463.99 Net Sales Growth 7.72% 8.27% -7.44% 9.50% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% Cost Of Goods Sold 378.61 354.69 330.99 386.98 340.79 174.31 181.95 205.08 227.07 238.51 268.94 Gross Profit 269.28 246.76 224.51 213.20 207.33 165.02 139.94 167.33 172.97 179.77 195.05 GP Margin 41.56% 41.03% 40.42% 35.52% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% Total Expenditure 584.36 541.85 495.49 538.07 494.35 298.52 289.37 332.94 349.32 337.11 374.81 Power & Fuel Cost - 6.35 5.52 4.71 4.58 4.73 4.86 4.29 4.14 4.01 3.80 % Of Sales - 1.06% 0.99% 0.78% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% Employee Cost - 66.95 57.05 52.33 46.02 46.02 42.10 39.31 34.27 32.44 32.36 % Of Sales - 11.13% 10.27% 8.72% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% Manufacturing Exp. - 28.77 32.40 31.57 22.86 20.84 21.01 36.10 42.48 15.70 17.29 % Of Sales - 4.78% 5.83% 5.26% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% General & Admin Exp. - 23.70 20.70 16.67 16.45 17.57 11.85 13.52 13.26 11.97 15.67 % Of Sales - 3.94% 3.73% 2.78% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% Selling & Distn. Exp. - 61.09 48.58 45.80 63.64 35.05 27.60 34.65 28.10 34.48 36.75 % Of Sales - 10.16% 8.75% 7.63% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% Miscellaneous Exp. - 0.31 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.75 % Of Sales - 0.05% 0.05% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 63.53 59.60 60.02 62.11 53.77 40.81 32.52 39.47 50.72 81.16 89.18 EBITDA Margin 9.81% 9.91% 10.80% 10.35% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% Other Income 20.96 11.58 10.32 8.31 19.63 5.31 6.09 2.39 4.28 2.01 0.68 Interest 0.06 0.09 0.12 0.48 13.02 13.34 25.41 35.56 36.38 37.98 41.21 Depreciation 22.50 26.44 32.30 33.53 35.28 32.01 33.98 33.83 40.26 41.68 46.00 PBT 71.84 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 Tax 26.51 16.15 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 Tax Rate 36.90% 36.18% 29.95% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% PAT 45.33 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 PAT before Minority Interest 45.33 28.49 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.00% 4.74% 4.78% 6.78% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% PAT Growth 59.16% 7.23% -34.75% -34.08% - - - - - -67.05% EPS 33.83 21.26 19.83 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 508.59 478.05 449.41 400.18 332.25 340.95 367.99 394.23 444.43 466.24 Share Capital 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 Total Reserves 495.22 464.68 436.05 374.09 319.91 328.61 355.65 381.89 432.99 454.79 Non-Current Liabilities 59.86 58.17 45.95 58.81 96.03 136.75 157.89 179.52 212.03 221.50 Secured Loans 0.00 0.00 0.00 0.00 23.92 60.88 86.02 112.69 134.55 150.91 Unsecured Loans 38.68 38.68 38.68 47.52 48.34 55.20 50.84 49.13 56.47 51.34 Long Term Provisions 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 Current Liabilities 72.81 72.67 82.61 87.82 215.98 254.46 222.61 193.71 177.59 157.06 Trade Payables 42.70 48.51 49.63 68.36 33.96 33.41 27.19 30.56 23.90 25.76 Other Current Liabilities 29.06 23.27 32.23 18.78 99.99 107.61 76.87 45.70 36.63 13.99 Short Term Borrowings 0.00 0.00 0.00 0.00 81.42 108.92 117.23 115.70 115.09 115.40 Short Term Provisions 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 Total Liabilities 641.26 608.89 577.97 546.81 644.26 732.16 748.49 767.46 834.05 844.80 Net Block 202.76 199.68 224.67 244.20 271.47 346.89 369.93 389.38 433.52 425.77 Gross Block 581.97 568.50 578.19 581.73 589.77 674.06 669.01 655.78 660.61 612.50 Accumulated Depreciation 379.21 368.82 353.52 337.53 318.30 327.17 299.08 266.40 227.09 186.73 Non Current Assets 280.26 290.70 313.57 333.08 360.33 478.57 499.96 517.54 575.53 618.72 Capital Work in Progress 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 Non Current Investment 0.16 0.14 0.14 0.14 0.14 0.14 0.14 28.74 28.74 28.74 Long Term Loans & Adv. 51.76 62.55 61.96 62.34 64.08 66.78 65.13 33.17 32.90 85.91 Other Non Current Assets 4.50 2.23 1.57 1.29 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 361.00 318.19 264.41 213.74 283.94 253.59 248.53 249.93 258.53 226.08 Current Investments 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 117.81 113.60 125.63 119.69 136.44 140.94 135.98 139.69 137.69 140.44 Sundry Debtors 89.54 84.92 30.41 16.44 29.78 31.39 44.15 41.91 53.88 59.37 Cash & Bank 67.64 53.30 49.97 30.24 1.44 1.28 3.64 3.15 3.04 3.52 Other Current Assets 66.91 1.78 5.25 5.70 116.28 79.98 64.77 65.18 63.91 22.76 Short Term Loans & Adv. 65.59 44.46 53.15 41.66 60.56 74.83 59.93 65.18 63.91 22.76 Net Current Assets 288.18 245.53 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 69.02 Total Assets 641.26 608.89 577.98 546.82 644.27 732.16 748.49 767.47 834.06 844.80

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 487.55 460.34 440.45 400.28 323.37 332.52 361.91 388.67 437.62 456.68 Share Capital 13.37 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 Total Reserves 474.18 446.97 427.08 374.19 311.03 320.18 349.57 376.33 426.18 445.24 Non-Current Liabilities 59.86 58.17 45.95 58.12 95.82 136.68 158.47 179.52 212.05 221.55 Secured Loans 0.00 0.00 0.00 0.09 24.19 61.29 86.60 112.69 134.57 150.95 Unsecured Loans 38.68 38.68 38.68 46.74 47.87 54.73 50.84 49.13 56.47 51.34 Long Term Provisions 10.26 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 Current Liabilities 79.42 82.57 92.74 97.45 224.58 263.62 230.38 196.81 193.14 162.83 Trade Payables 44.14 50.84 50.17 71.36 36.70 36.00 29.33 29.73 25.14 29.56 Other Current Liabilities 31.57 27.23 37.76 21.10 101.70 110.30 78.47 46.16 42.71 15.96 Short Term Borrowings 2.65 3.61 4.06 4.30 85.58 112.80 121.26 119.16 123.32 115.40 Short Term Provisions 1.05 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 Total Liabilities 626.83 601.08 579.14 555.85 643.77 732.82 750.76 765.00 842.81 841.06 Net Block 218.53 215.96 240.94 261.68 289.37 364.45 389.20 406.18 452.48 443.65 Gross Block 617.51 603.75 612.50 616.32 623.96 707.02 702.77 686.50 679.57 641.12 Accumulated Depreciation 398.98 387.78 371.57 354.63 334.59 342.57 313.57 280.32 227.09 197.47 Non Current Assets 267.30 278.25 301.10 321.82 349.77 467.39 490.50 505.60 565.75 607.85 Capital Work in Progress 21.08 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 Non Current Investment 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 23.16 33.95 33.36 35.03 35.77 38.18 36.53 33.17 32.90 85.91 Other Non Current Assets 4.50 2.23 1.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 359.52 322.83 278.04 234.03 294.00 265.43 260.27 259.41 277.07 233.21 Current Investments 19.09 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 121.69 119.94 125.64 119.99 141.12 142.73 138.17 140.60 143.29 142.87 Sundry Debtors 80.50 76.66 38.60 32.04 30.69 38.04 47.27 47.29 61.59 63.22 Cash & Bank 68.09 54.45 50.40 31.42 2.13 2.81 3.98 3.56 7.07 3.62 Other Current Assets 70.15 1.78 5.01 5.70 120.06 81.85 70.84 67.96 65.12 23.51 Short Term Loans & Adv. 68.83 49.87 58.39 44.88 64.34 76.70 66.00 67.96 65.12 23.51 Net Current Assets 280.11 240.26 185.30 136.59 69.43 1.81 29.88 62.59 83.93 70.38 Total Assets 626.82 601.08 579.14 555.85 643.77 732.82 750.77 765.01 842.82 841.06

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 35.38 28.05 41.00 132.34 77.75 43.65 51.58 61.77 41.91 66.76 PBT 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 Adjustment 19.36 22.25 24.83 21.59 40.39 59.20 64.73 69.30 53.72 81.90 Changes in Working Capital -15.15 -34.53 -28.50 69.69 20.37 3.75 10.27 17.27 -14.82 -17.18 Cash after chg. in Working capital 50.87 28.05 41.00 108.89 63.31 43.65 51.58 61.77 41.91 66.76 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -6.94 -50.81 -16.75 55.98 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 Net Fixed Assets -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 Net Investments 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 Others 0.49 -39.50 -20.17 48.42 -129.06 -6.22 -28.34 -37.01 53.38 0.24 Cash from Financing Activity 0.00 0.00 -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 Net Cash Inflow / Outflow 28.44 -22.76 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 Opening Cash & Equivalents 20.07 42.83 27.70 0.00 0.50 3.64 3.15 3.04 3.52 4.38 Closing Cash & Equivalent 48.51 20.07 42.83 26.45 1.26 1.28 3.64 3.15 3.04 3.52

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 37.29 36.63 41.10 131.84 77.60 45.33 31.19 58.93 46.88 67.80 PBT 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 Adjustment 20.23 23.33 26.33 21.89 41.56 60.72 66.24 70.61 56.41 83.56 Changes in Working Capital -12.11 -24.63 -21.64 61.39 20.82 5.37 -7.52 9.96 -13.04 -18.40 Cash after chg. in Working capital 52.77 36.63 41.10 108.39 63.16 45.33 31.19 58.93 46.88 67.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -15.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.21 -50.83 -16.73 56.49 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 Net Fixed Assets -8.45 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 Net Investments 1.02 -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 Others 0.22 -39.52 -20.15 48.93 -129.17 -6.28 -28.34 -37.27 53.10 0.21 Cash from Financing Activity -1.08 -0.57 -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 Net Cash Inflow / Outflow 28.99 -14.77 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 Opening Cash & Equivalents 21.21 43.26 28.88 1.94 2.03 3.98 0.00 7.07 3.62 4.41 Closing Cash & Equivalent 48.96 21.21 43.26 28.88 1.94 2.81 -19.52 3.56 7.07 3.62

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 380.48 357.63 336.21 313.10 269.21 276.25 298.16 319.42 388.42 407.48 ROA 4.88% 4.88% 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% ROE 6.18% 6.25% 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% ROCE 8.77% 8.03% 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% Fixed Asset Turnover 1.00 0.94 0.99 0.88 0.51 0.45 0.54 0.57 0.63 0.77 Receivable days 55.35 39.15 14.83 16.39 34.86 45.68 44.23 46.56 51.33 49.34 Inventory Days 73.42 81.20 77.63 90.83 158.08 167.43 141.69 134.83 126.05 113.85 Payable days 47.26 53.20 57.04 55.46 42.49 37.63 31.43 27.90 25.33 24.89 Cash Conversion Cycle 81.51 67.15 35.41 51.76 150.45 175.48 154.49 153.50 152.04 138.30 Total Debt/Equity 0.08 0.08 0.09 0.12 0.65 0.86 0.82 0.78 0.74 0.68 Interest Cover 0.00 0.00 0.00 4.23 0.52 -0.12 0.34 0.31 1.08 1.05

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 364.74 344.38 329.50 313.18 262.01 269.42 293.23 314.92 382.47 399.13 ROA 4.64% 4.50% 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% ROE 6.01% 5.90% 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% ROCE 8.67% 7.72% 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% Fixed Asset Turnover 0.99 0.91 0.98 0.88 0.51 0.46 0.54 0.59 0.63 0.76 Receivable days 47.69 37.87 21.48 20.89 36.97 48.37 46.34 49.67 54.45 50.42 Inventory Days 73.32 80.68 74.69 86.94 152.66 159.26 136.61 129.51 124.86 112.15 Payable days 48.87 55.69 57.31 57.86 42.82 37.91 30.30 26.74 26.74 27.25 Cash Conversion Cycle 72.13 62.86 38.86 49.96 146.80 169.72 152.65 152.44 152.57 135.32 Total Debt/Equity 0.08 0.09 0.10 0.13 0.68 0.90 0.85 0.80 0.77 0.70 Interest Cover 477.45 322.44 76.69 4.73 0.40 -0.17 0.23 0.41 1.09 1.06

Top Investors:

pradeep kumar jain

rajni tarun jain

acadian emerging markets micro-cap equity master fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Venus Remedies secures Ukrainian GMP renewal
22nd May 2025, 14:30 PM

The certification applies to the company's Unit-II manufacturing facility located in Baddi, Himachal Pradesh
Read More
USFDA grants QIDP Designation to Venus Remedies’ investigational product VRP-034
17th Apr 2025, 12:59 PM

This recognition by USFDA strengthens Venus Remedies’ commitment to innovation in the fight against AMR
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback